Loading...

Bio-Rad Laboratories, Inc.

BIO-B•NYSE
Healthcare
Medical - Devices
$247.05
$0.00(0.00%)

Bio-Rad Laboratories, Inc. (BIO-B) Stock Overview

Explore Bio-Rad Laboratories, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 69.6/100

Key Financials

Market Cap6.7B
P/E Ratio25.22
EPS (TTM)$-76.53
ROE0.05%
Fundamental Analysis

AI Price Forecasts

1 Week$258.20
1 Month$258.97
3 Months$340.39
1 Year Target$268.65

BIO-B Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Bio-Rad Laboratories, Inc. (BIO-B) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 34.77, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $268.65.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 25.22 and a market capitalization of 6.7B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-6.90%
5-Day Change
-6.90%
1-Month Change
-15.25%
3-Month Change
-33.93%
6-Month Change
-32.72%
Year-to-Date (YTD) Change
-30.81%
1-Year Change
-19.51%
3-Year Change
-61.78%
5-Year Change
-43.74%
All-Time (Max) Change
1616.50%

Contact Information

https://www.bio-rad.com
510 724 7000
1000 Alfred Nobel Drive, Hercules, CA, 94547

Company Facts

7,700 Employees
IPO DateSep 21, 1999
CountryUS
Actively Trading

Frequently Asked Questions

;